| Disease phenotype | Itemin
 this
 table
 | Key references
 | Gene symbol (chromosome)
 protein
 | All allelic disease phenotypes - locus/disease symbols | 
| Myasthenic syndrome, congenital, 1A, Slow-channel - (AD) | 11.1 |  | | |  |  | Cholinergic receptor, nicotinic, alpha polypeptide 1
 | 
 | 
 | |  | * Myasthenic syndrome, fast-channel congenital - FCCMS |  |  | * Myasthenic syndrome, slow-channel congenital - SCCMS |  |  | * Myasthenic syndrome, congenital associated with acetylcholine receptor deficiency |  |  | * Myasthenic syndrome, congenital, 1B, Fast-channel - CMS1B |  |  | * Myasthenic syndrome, congenital, 1A, Slow-channel - CMS1A | 
 | 
| Myasthenic syndrome, congenital, 2A, Slow-channel - (AD) | 11.2 |  | | |  |  | Cholinergic receptor, nicotinic, beta 1 muscle
 | 
 | 
 | |  | * Myasthenic syndrome, congenital, Ie, included - CMS1E |  |  | * Myasthenic syndrome, slow-channel congenital - SCCMS |  |  | * Myasthenic syndrome, congenital, 2B, Fast-channel - CMS2B |  |  | * Myasthenic syndrome, congenital, 2A, Slow-channel - CMS2A | 
 | 
| Myasthenic syndrome, congenital, 3A, Slow-channel - (AD) | 11.3 |  | | |  |  | Cholinergic receptor, nicotinic, delta
 | 
 | 
 | |  | * Myasthenic syndrome, slow-channel congenital - SCCMS |  |  | * Myasthenic syndrome, fast-channel congenital  - FCCMS |  |  | * Myasthenic syndrome, congenital, 3B, Fast-channel - CMS3B | 
 | 
| Myasthenic syndrome, congenital, 4A, Slow-channel - (AD, AR) | 11.4 |  | | |  |  | Cholinergic receptor, nicotinic, epsilon
 | 
 | 
 | |  | * Myasthenic syndrome, fast-channel congenital  - FCCMS |  |  | * Myasthenic syndrome, slow-channel congenital - SCCMS |  |  | * Myasthenic syndrome, congenital, 4C, associated with acetylcholine receptor deficiency - CMS4C | 
 | 
| Myasthenic syndrome, congenital, 1B, Fast-channel - (AR) | 11.5 |  | | |  |  | Cholinergic receptor, nicotinic, alpha polypeptide 1
 | 
 | 
 | |  | * Myasthenic syndrome, fast-channel congenital - FCCMS |  |  | * Myasthenic syndrome, slow-channel congenital - SCCMS |  |  | * Myasthenic syndrome, congenital associated with acetylcholine receptor deficiency |  |  | * Myasthenic syndrome, congenital, 1B, Fast-channel - CMS1B |  |  | * Myasthenic syndrome, congenital, 1A, Slow-channel - CMS1A | 
 | 
| Myasthenic syndrome, congenital, 2B, Fast-channel - (AR) | 11.6 |  | | |  |  | Cholinergic receptor, nicotinic, beta 1 muscle
 | 
 | 
 | |  | * Myasthenic syndrome, congenital, Ie, included - CMS1E |  |  | * Myasthenic syndrome, slow-channel congenital - SCCMS |  |  | * Myasthenic syndrome, congenital, 2B, Fast-channel - CMS2B |  |  | * Myasthenic syndrome, congenital, 2A, Slow-channel - CMS2A | 
 | 
| Myasthenic syndrome, congenital, 3B, Fast-channel - (AR) | 11.7 |  | | |  |  | Cholinergic receptor, nicotinic, delta
 | 
 | 
 | |  | * Myasthenic syndrome, slow-channel congenital - SCCMS |  |  | * Myasthenic syndrome, fast-channel congenital  - FCCMS |  |  | * Myasthenic syndrome, congenital, 3B, Fast-channel - CMS3B | 
 | 
| Myasthenic syndrome, congenital, 4B, Fast-channel - (AR) | 11.8 |  | | |  |  | Cholinergic receptor, nicotinic, epsilon
 | 
 | 
 | |  | * Myasthenic syndrome, fast-channel congenital  - FCCMS |  |  | * Myasthenic syndrome, slow-channel congenital - SCCMS |  |  | * Myasthenic syndrome, congenital, 4C, associated with acetylcholine receptor deficiency - CMS4C | 
 | 
| Myasthenic syndrome, congenital, 2C, associated with acetylcholine receptor deficiency - (AR) | 11.9 |  | | |  |  | Cholinergic receptor, nicotinic, beta 1 muscle
 | 
 | 
 | |  | * Myasthenic syndrome, congenital, Ie, included - CMS1E |  |  | * Myasthenic syndrome, slow-channel congenital - SCCMS |  |  | * Myasthenic syndrome, congenital, 2B, Fast-channel - CMS2B |  |  | * Myasthenic syndrome, congenital, 2A, Slow-channel - CMS2A | 
 | 
| Myasthenic syndrome, congenital, 3C, associated with acetylcholine receptor deficiency - (AR) | 11.10 |  | | |  |  | Cholinergic receptor, nicotinic, delta
 | 
 | 
 | |  | * Myasthenic syndrome, slow-channel congenital - SCCMS |  |  | * Myasthenic syndrome, fast-channel congenital  - FCCMS |  |  | * Myasthenic syndrome, congenital, 3B, Fast-channel - CMS3B | 
 | 
| Myasthenic syndrome, congenital, 4C, associated with acetylcholine receptor deficiency - (AR) | 11.11 |  | | |  |  | Cholinergic receptor, nicotinic, epsilon
 | 
 | 
 | |  | * Myasthenic syndrome, fast-channel congenital  - FCCMS |  |  | * Myasthenic syndrome, slow-channel congenital - SCCMS |  |  | * Myasthenic syndrome, congenital, 4C, associated with acetylcholine receptor deficiency - CMS4C | 
 | 
| Myasthenic syndrome, congenital, 5 - (AR) | 11.12 |  | | |  |  | Acetylcholinesterase collagen-like tail subunit
 | 
 | 
 | |  | * Congenital myasthenic syndrome with endplate acetylcholinesterase deficiency - EAD |  |  | * Myasthenic syndrome, congenital, 5 - CMS5 | 
 | 
| Myasthenic syndrome, congenital, 6, presynaptic - (AR) | 11.13 |  | | |  |  | Choline acetyltransferase isoform
 | 
 | 
 | |  | * Myasthenia gravis, autosomal recessive - MGI |  |  | * Myasthenia gravis, familial infantile - FIMG |  |  | * Congenital myasthenic syndrome with choline acetyltransferase deficiency - CMS-EA |  |  | * Myasthenia gravis, familial infantile, 2 - FIMG2 |  |  | * Myasthenic syndrome, congenital, 6, presynaptic - CMS6 | 
 | 
| Myasthenic syndrome, congenital, 7, presynaptic and distal motor neuropathy, autosomal dominant - (AD) | 11.14 |  |  | |  | * Myasthenic syndrome, presynaptic, congenital, with or without motor neuropathy - MYSPC |  |  | * Distal motor neuropathy related to SYT2 |  |  | * Myasthenic syndrome, congenital, 7B, presynaptic - CMS7B |  |  | * Myasthenic syndrome, congenital, 7, presynaptic and distal motor neuropathy, autosomal dominant - CMS7A | 
 | 
| Myasthenic syndrome, congenital, 7B, presynaptic, autosomal recessive - (AR) | 11.15 |  |  | |  | * Myasthenic syndrome, presynaptic, congenital, with or without motor neuropathy - MYSPC |  |  | * Distal motor neuropathy related to SYT2 |  |  | * Myasthenic syndrome, congenital, 7B, presynaptic - CMS7B |  |  | * Myasthenic syndrome, congenital, 7, presynaptic and distal motor neuropathy, autosomal dominant - CMS7A | 
 | 
| Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects - (AR) | 11.16 |  |  | |  | * Familial limb girdle myasthenia related to agrin - CMS1B |  |  | * Fetal akinesia deformation related to AGRN | 
 | 
| Myasthenic syndrome, congenital, 9, associated with acetylcholine receptor deficiency - (AR) | 11.17 |  | | |  |  | Muscle, skeletal, receptor tyrosine kinase
 | 
 | 
 | |  | * Congenital myasthenic syndrome related to MuSK - CMS1B |  |  | * Fetal akinesia deformation sequance with MUSK defect - FADS1 |  |  | * Myasthenic syndrome, congenital, 9, associated with acetylcholine receptor deficiency - CMS9 | 
 | 
| Myasthenic syndrome, congenital, 10 - (AR) | 11.18 |  |  | |  | * Familial limb-girdle myasthenia related to DOK7 - CMS1B |  |  | * Fetal akinesia deformation sequence 3 - FADS3 |  |  | * Myasthenic syndrome, congenital, 10 - CMS10 | 
 | 
| Myasthenic syndrome, congenital, 11, associated with acetylcholine receptor deficiency - (AR) | 11.19 |  |  | |  | * Myasthenic syndrome, congenital - CMS1D |  |  | * Fetal akinesia deformation sequence 2 - FADS2 |  |  | * Myasthenic syndrome, congenital, 11, associated with acetylcholine receptor deficiency - CMS11 | 
 | 
| Myasthenia, congenital, 12, with tubular aggregates - (AR) | 11.20 |  | | |  |  | Glutamine-fructose-6-phosphate transaminase 1
 | 
 | 
 | |  | * Familial limb girdle myasthenia with tubular aggregates related to GFPT1 - CMSTA1 |  |  | * Myasthenia, congenital, 12, with tubular aggregates - CMS12 | 
 | 
| Myasthenic syndrome, congenital, 13, with tubular aggregates - (AR) | 11.21 |  | | |  |  | Dolichyl-phosphate (UDP-N-acetylglucosamine) N-acetylglucosaminephosphotransferase 1 (GlcNAc-1-P transferase)
 | 
 | 
 | |  | * Familial imb-girdle myasthenia  with tubular aggregates related to DPAGT1 - CMSTA2 |  |  | * Myasthenic syndrome, congenital, 13, with tubular aggregates - CMS13 | 
 | 
| Myasthenic syndrome, congenital, 14, with tubular aggregates - (AR) | 11.22 |  | | |  |  | Alpha-1,3/1,6-mannosyltransferase
 | 
 | 
 | |  | * Myasthenic syndrome, congenital, 14, with tubular aggregates - CMS14 | 
 | 
| Myasthenic syndrome, congenital, 15, without tubular aggregates - (AR) | 11.23 |  | | |  |  | UDP-N-acetylglucosaminyltransferase
 | 
 | 
 | |  | * Myasthenic syndrome, congenital, 15, without tubular aggregates  - CMS15 | 
 | 
| Myasthenic syndrome, congenital, 16 - (AR) | 11.24 |  | | |  |  | Sodium channel, voltage-gated, type IV, alpha
 | 
 | 
 | |  | * Hyperkalemic periodic paralysis - HYPP |  |  | * Myotonia potassium-aggravatd |  |  | * Sodium-channel myasthenia |  |  | * Myasthenic syndrome, acetazolamide-responsive |  |  | * Myasthenic syndrome, congenital, 16  - CMS16 |  |  | * Severe foetal hypokinesia related to SCN4A |  |  | * Congenital Myopathy 22B, severe fetal - CMYP22B |  |  | * Congenital Myopathy 22A, classic - CMYP22A |  |  | * Hyperkalemic periodic paralysis, type 2 - HOKPP2 |  |  | * Paramyotonia congenita of Von Eulenburg - PMC |  |  | * Potassium-aggravated myotonia | 
 | 
| Myasthenic syndrome, congenital, 17 - (AR) | 11.25 |  | | |  |  | LDL receptor related protein 4
 | 
 | 
 | |  | * Congenital myasthenic syndrome - CMS17 | 
 | 
| Myasthenic syndrome, congenital, 18 - (AD) | 11.26 |  | | |  |  | Synaptosome associated protein 25
 | 
 | 
 | |  | * Congenital myasthenic syndrome with intellectual disability and ataxia - CMS18 | 
 | 
| Congenital myasthenic syndrome type 19 - (AR) | 11.27 |  | | |  |  | Collagen type XIII alpha 1 chain
 | 
 | 
 | |  | * Congenital myasthenic syndrome type 19 - CMS19 | 
 | 
| Myasthenic syndrome, congenital, 20, presynaptic - (AR) | 11.28 |  | | |  |  | Solute carrier family 5 (sodium/choline cotransporter), member 7
 | 
 | 
 | |  | * Neuronopathy, distal hereditary motor, type VIIA, with vocal cord paralysis (Harper-Young) - HMND7 |  |  | * Congenital myasthenic syndrome with episodic apnea - CMS20 | 
 | 
| Myasthenic syndrome, congenital, 21, presynaptic - (AR) | 11.29 |  | | |  |  | Solute Carrier Family 18 (Vesicular Acetylcholine), Member 3
 | 
 | 
 | |  | * Myasthenic Syndrome, Congenital, 21, Presynaptic - CMS21 | 
 | 
| Myasthenic syndrome, congenital, 22 | 11.30 |  | | |  |  | Prolyl endopeptidase-like
 | 
 | 
 | |  | * Myasthenic syndrome, congenital, 22 - CMS22 | 
 | 
| Myasthenic syndrome, congenital, 23, presynaptic - (AR) | 11.31 |  | | |  |  | Solute carrier family 25 (mitochondrial carrier, citrate transporter), member 1(M)
 | 
 | 
 | |  | * Presynaptic congenital myasthenic syndrome 23 - CMS23 | 
 | 
| Myasthenic syndrome, congenital, 24, presynaptic - (AR) | 11.32 |  |  | |  | * Presynaptic congenital myasthenic syndrome 24 - CMS24 | 
 | 
| Myasthenic syndrome, congenital, 25 - (AR) | 11.33 |  | | |  |  | Vesicle associated membrane protein  (synaptobrevin 1)(M)
 | 
 | 
 | |  | * ataxia, spastic, 1, autosomal dominant - SPAX1 |  |  | * Presynaptic congenital myasthenic syndrome 25 - CMS25 | 
 | 
| Congenital myasthenic syndrome with nephrotic syndrome - (AR) | 11.34 |  | | |  |  | Laminin, beta 2 (laminin S)
 | 
 | 
 | |  | * Congenital myasthenic syndrome with nephrotic syndrome - NPHS5 | 
 | 
| Escobar syndrome  (multiple pterygium syndrome) - (AR) | 11.35 |  | | |  |  | Cholinergic receptor, nicotinic, gamma polypeptide
 | 
 | 
 | |  | * Escobar syndrome  (multiple pterygium syndrome) - EVMPS | 
 | 
| Myasthenic syndrome, with plectin defect - (AR) | 11.36 |  |  | |  | * Limb-girdle, muscular dystrophy, type 2q - LGMD2Q |  |  | * Epidermolysis bullosa simplex associated with late-onset muscular dystrophy - MDEBS |  |  | * Myasthenic syndrome, with plectin defect |  |  | * Limb girdle muscular dystrophy with ophthalmoplegia | 
 | 
| Congenital Myasthenic syndrome related to GMPPB - (AR) | 11.37 |  | | |  |  | GDP-mannose pyrophosphorylase B
 | 
 | 
 | |  | * Muscle-eye-brain disease - MDDGA14 |  |  | * Limb-Girdle, Muscular dystrophy, type 2T - MDDGC14 |  |  | * Congenital Myasthenic syndrome related to GMPPB | 
 | 
| Presynaptic congenital myasthenic syndrome - (AR) | 11.38 |  |  | |  | * Presynaptic congenital myasthenic syndrome | 
 | 
| Presynaptic congenital myasthenic syndrome related to MUNC13-1 - (AR) | 11.39 |  | | |  |  | Unc-13 homolog A (C. elegans)
 | 
 | 
 | |  | * Presynaptic congenital myasthenic sydrome related to MUNC13-1 | 
 | 
| Congenital myasthenic syndrome related to RPH3A - (AR) | 11.40 |  |  | |  | * Congenital myasthenic syndrome related to RPH3A | 
 | 
| Congenital myasthenic syndrome - (AR) | 11.41 |  | | |  |  | Torsin A interacting protein 1
 | 
 | 
 | |  | * LAP1B related muscular dystrophy |  |  | * Limb-Girdle, Muscular dystrophy, type 2Y - LGMD2Y |  |  | * Myopathy, autosomal recessive, with rigid spine and distal joint contractures - MRRSDC |  |  | * Congenital myasthenic syndrome | 
 | 
| Congenital myasthenic syndrome - (AD) | 11.42 |  | | |  |  | Chromodomain Helicase DNA-Binding Protein 8
 | 
 | 
 | |  | * Congenital myasthenic syndrome | 
 | 
| Myasthenic syndrome, congenital associated with acetylcholine receptor deficiency - (AR) | 11.43 |  | | |  |  | Cholinergic receptor, nicotinic, alpha polypeptide 1
 | 
 | 
 | |  | * Myasthenic syndrome, fast-channel congenital - FCCMS |  |  | * Myasthenic syndrome, slow-channel congenital - SCCMS |  |  | * Myasthenic syndrome, congenital associated with acetylcholine receptor deficiency |  |  | * Myasthenic syndrome, congenital, 1B, Fast-channel - CMS1B |  |  | * Myasthenic syndrome, congenital, 1A, Slow-channel - CMS1A | 
 | 
| Myopathy, cardiomyopathy and  congenital myasthenic syndrome - (AR) | 11.44 |  |  | |  | * Desmin-related myopathy - DRM |  |  | * Limb-Girdle, Muscular dystrophy, type 2R - LGMD2R |  |  | * Dilated cardiomyopathy, 1I - CMD1I |  |  | * Arrhythmogenic right ventricular dysplasia with myofibrillar myopathy - ARVD7 |  |  | * Myofibrillar myopathy 1 - MFM1 |  |  | * Myopathy, cardiomyopathy and congenital myasthenic syndrome |  |  | * Limb girdle muscular dystrophy 1E (autosomal dominant)  - LGMD1E | 
 | 
| PURA syndrome with neurmuscular  junction manisfestations - (AD) | 11.45 |  | | |  |  | Purine-rich element-binding protein A
 | 
 | 
 | |  | * PURA syndrome with neurmuscular  junction manisfestations - NEDRIHF | 
 |